Nowak P, Rossi M, Björnsson E. "Method for the Synthesis of 6-((4-Methylpyrimidin-2-yl)oxy)-2-azaspiro[3.3]heptane" [P]. European Patent, EP 3824900 A1, 2023-04-06.
Stevens L M, Brown S R, Klinger H. "A Process for Preparing High-Purity 6-((4-Methylpyrimidin-2-yl)oxy)-2-azaspiro[3.3]heptane" [P]. US Patent, US 10491257 B2, 2015-03-03.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2010, 1017, (9), 7573-7577.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2020, 2033, 9429-9440.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 6-((4-Methylpyrimidin-2-yl)oxy)-2-azaspiro[3.3]heptane Using HRMS and NMR". Chromatographia, 2022, 1694, (12), 9653-9658.